Newsroom

Written by Michael McCullar, Ph.D. Feb. 1, 2022 The ability to differentiate in a competitive marketplace lies in developing key...

Full Title: OnQuality Pharmaceuticals to Present Oncologist Survey Data Demonstrating Need for New Cancer Therapy-Associated Diarrhea...

Mark Terry January 10, 2022 https://www.biospace.com/article/-clinical-catch-up-january-3-7 The biopharma industry has started 2022 with...

Heather McKenzie January 10, 2022 https://www.biospace.com/article/executive-perspectives-on-2022-/ After a decade of breakthroughs in...

By Sara Karlovitch OQL011, for cancer therapy induced skin toxicity, demonstrated a tolerable safety and acceptable efficacy profile,...

Therapy Induced Skin Toxicity that Met Expectations - Part 1 of the Phase 2 NOVA-II clinical trial evaluating OQL011 met the company's...

David E. Williams November 11, 2021 Hong Tang grew up in rural China, and was encouraged by her pharmacist sister to become a physician....

Moira Gunn November 9 On this week’s Tech Nation, Moira speaks with Dr. Sidarta Ribeiro, Deputy Director of the Brain Institute at the...

To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and...